Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine whether prostate tumors remain sensitive to treatment or evolve into a more ...
A new study shows that an interpretable AI model fusing 18F-PSMA-1007 PET/CT and multiparametric MRI can predict prostate ...
Tampere University Hospital (Tays) has begun offering a new form of radiotherapy to treat rectal cancer in which a high dose ...
Fagundes, MD, discussed when proton therapy is most justified over photon approaches in prostate cancer. In an interview with ...
PSMA PET/CT-targeted biopsy detects more clinically significant prostate cancer than systematic biopsy alone in men with ...
Adding aglatimagene besadenovec (CAN-2409) to external beam radiation therapy (EBRT) was associated with greater lymphocyte infiltration of prostate tissue and greater lymphocyte- ...
PACE is the first phase 3 randomized trial directly comparing radical prostatectomy with SBRT in men with low- to intermediate-risk prostate cancer.
Experts discuss considerations for other androgen receptor inhibitors, highlighting their role in treatment strategies and how they impact patient outcomes in prostate cancer. Experts discuss the role ...
Innovative techniques using electrical energy to treat bladder cancer may lower recurrence rates and minimize the need for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results